There are little or no reports on the methylation status of RHBDD2, but it was found to be overexpressed in CRC [59], breast cancer [60,61], and as a pathogenic gene in familial non-medullary thyroid cancer (FNMTC) [62]. The gene discussed is RHBDD2; the disease is familial papillary or follicular thyroid carcinoma.